Osteoporosis affects approximately three million people in the United Kingdom, with women accounting for the substantial majority of that number. The public health response to this burden has focused heavily on calcium and vitamin D, a combination that has been the centrepiece of NHS guidance on bone health for decades. This guidance is appropriate as far as it goes. Its limitation is that it addresses one structural mineral and its absorption cofactor in a biological system that requires eight minerals to function at its capacity for maintaining bone density and structural integrity.
She-Lajit addresses the complete trace mineral spectrum that bone health requires through shilajit's 85+ ionic minerals delivered via fulvic acid. The calcium conversation is a necessary starting point. It is not sufficient. Here is what British women need to understand about the minerals their bone health is most likely missing.
Why the calcium and vitamin D focus is necessary but not complete
Bone mineral is built primarily from hydroxyapatite, a calcium phosphate crystal that forms within an organic collagen matrix. Hydroxyapatite provides the compressive strength of bone. The collagen matrix provides tensile strength and structural flexibility. Both components are essential. Both require not only calcium but a coordinated team of minerals operating as structural components and enzymatic cofactors throughout the bone-building and bone-maintenance process.
Calcium supplementation ensures calcium is available in circulation. What determines whether that calcium is effectively deposited into bone, incorporated into hydroxyapatite crystals, and maintained within the collagen matrix, is the availability of the other minerals that make the cellular processes of bone formation functional.
A British woman conscientiously taking her calcium and vitamin D without adequate magnesium, zinc, manganese, and copper may have circulating calcium available for bone deposition but insufficient enzymatic machinery to complete that deposition efficiently. The mineral is present. The cellular system that would use it is running below capacity.
Magnesium: the mineral that makes calcium supplementation function correctly
Magnesium's relevance to bone health is threefold and each mechanism is independently significant.
Approximately 60 percent of the body's total magnesium is stored in bone tissue. When dietary magnesium is inadequate, serum magnesium is maintained at the expense of bone magnesium stores. The body preferentially keeps blood magnesium stable by drawing from bone reserves, progressively depleting bone mineral content in the process. A woman with low dietary magnesium may have normal serum magnesium and be simultaneously losing bone magnesium every day.
Magnesium is also the cofactor required for osteoblast cellular function. Osteoblasts are the bone-forming cells that synthesise collagen matrix and initiate mineralisation. Their activity depends on adequate intracellular magnesium. Reduced osteoblast efficiency means slower bone formation in the continuous remodelling cycle.
The third mechanism is the vitamin D connection that most British women following NHS calcium and vitamin D guidance are entirely unaware of. The enzyme that converts vitamin D to its active 1,25-dihydroxyvitamin D form in the kidney, 25-hydroxyvitamin D-1-alpha-hydroxylase, requires magnesium as a cofactor. Supplementing vitamin D without adequate magnesium produces circulating inactive vitamin D rather than the active form that drives intestinal calcium absorption. The calcium and vitamin D strategy can fail to work at the absorption stage if magnesium is inadequate.
Zinc and the mineralisation enzymes that calcium cannot activate alone
Alkaline phosphatase is the enzyme responsible for mineralising the collagen matrix of bone, precipitating calcium and phosphate as hydroxyapatite crystals within the organic scaffold. Alkaline phosphatase is zinc-dependent. Without adequate zinc, the mineralisation enzyme that actually deposits calcium into bone runs below capacity.
Zinc additionally supports the cellular balance of bone remodelling through two complementary effects: stimulating osteoblast differentiation and activity, promoting bone formation, while inhibiting osteoclast activity, slowing bone resorption. This dual action on the cellular balance of bone turnover makes zinc a mineral that addresses both sides of the density equation simultaneously.
Copper and why bone strength is not the same as bone density
DXA scan measurements, the gold standard for bone health assessment in British clinical practice, measure mineral density per unit of bone volume. They do not directly assess structural bone strength, which depends on the mechanical properties of the collagen matrix into which minerals are deposited.
Collagen in bone is mechanically reinforced through cross-linking, the formation of covalent bonds between adjacent collagen fibres by the enzyme lysyl oxidase. These cross-links give bone its tensile strength and resistance to fracture under bending and torsional forces. Lysyl oxidase is copper-dependent. Without adequate copper, collagen cross-linking is reduced, producing bone that may measure adequately on a DXA scan but fractures more readily under mechanical load than its density would predict.
The clinical implication for British women focused on fracture prevention rather than simply density scores is that copper adequacy is relevant to actual fracture risk independently of what bone density measurements show.
Silicon, manganese, boron, and the minerals completing the picture
Silicon stimulates collagen synthesis, the production of the organic matrix framework into which all bone mineral is subsequently incorporated. Bone is approximately 35 percent collagen by dry weight, and adequate collagen synthesis is the prerequisite for mineralisation having a matrix to occur within. Manganese is a cofactor for the enzymes producing bone matrix proteoglycans, the structural molecules filling the space between collagen fibres and contributing to bone's mechanical behaviour.
Boron supports calcium and magnesium retention in the body and is associated with oestrogen metabolism, making it particularly relevant to British women in perimenopause. Oestrogen supports osteoblast bone formation and inhibits osteoclast bone resorption. Its progressive decline through perimenopause accelerates bone loss from both cellular directions simultaneously.
She-Lajit's shatavari component, containing phytoestrogenic saponins associated with oestrogen receptor support, combined with shilajit's complete trace mineral profile, addresses both the hormonal and the mineral dimensions of perimenopausal bone health through a single daily product.
Our She-Lajit Honey Sticks deliver shilajit's 85+ ionic minerals through fulvic acid alongside shatavari and saffron in raw Himalayan honey. GMP-certified. FSA-compliant. Third-party tested on every batch.
Conclusion
Three million Britons are managing osteoporosis, and the vast majority are women. The calcium and vitamin D strategy that NHS guidance recommends is appropriate and valuable. It addresses one structural mineral and its immediate absorption cofactor in a biological system that requires seven additional minerals to complete the cellular machinery of bone formation, mineralisation, matrix cross-linking, and remodelling. British women whose bone health strategy ends with calcium and vitamin D are supporting part of the system. She-Lajit's trace mineral spectrum supports the rest.
